[BioCentury] After building and validating its AI-driven small molecule discovery platform through partnerships, Atomwise has raised a $123 million series B round that will enable the company to begin building its
Porcine Reproductive and Respiratory Syndrome (PRRS) virus is the most economically damaging virus for global pork production, responsible for approximately $600 million in annual losses for American pig farmers alone.
Small molecule found to block CD163 surface receptor, which PRRS virus needs to infect pig cells and cause disease.
University of Connecticut (UConn) researchers have identified a compound that can successfully block the Porcine Reproductive and Respiratory Syndrome (PRRS) virus.
Drug discovery startup Atomwise and stroke risk predictor Viz.ai are among a group of seven healthcare companies recognized by Forbes for their artificial intelligence capabilities.
As Covid-19 continues to threaten lives and livelihoods around the world, a great emphasis has been put on preventing and treating the disease. However, putting a human drug through the FDA approval process costs hundreds of millions of dollars and takes months, if not years, of clinical trials. What if one of the over 7,800 […]